RecruitingPhase 3NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Sponsor: Bristol-Myers Squibb
Oklahoma City, OK · +120 more sites
3 recruiting psoriasis studies with a site in Oklahoma City, OK.
Sponsor: Bristol-Myers Squibb
Oklahoma City, OK · +120 more sites
Sponsor: Janssen Research & Development, LLC
Oklahoma City, OK · +24 more sites
Sponsor: UCB Biopharma SRL
Oklahoma City, OK · +7 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.